We examined the mechanism by which adenosine inhibits prolactin secretion from GH3 cells, a rat pituitary tumour line. Prolactin release is enhanced by vasoactive intestinal peptide (VIP), which increases cyclic AMP, and by thyrotropin-releasing hormone (TRH), which increases inositol phosphates (IPx). Analogues of adenosine decreased prolactin release, VIP-stimulated cyclic AMP accumulation and TRH-stimulated inositol phospholipid hydrolysis and IP, generation. Inhibition of InsP3 production by R-N6-phenylisopropyladenosine (R-PIA) was rapid (15 s) and was not affected by the addition of forskolin or the removal of external Ca2". Addition of adenosine deaminase or the potent adenosine-receptor antagonist, BW-A1433U, enhanced the accumulation of cyclic AMP by VIP, indicating that endogenously produced adenosine tonically inhibits adenylate cyclase. The potency order of adenosine analogues for inhibition of cyclic AMP and IPX responses (measured in the presence of adenosine deaminase) was N6-cyclopentyladenosine > R-PIA > 5'-N-ethylcarboxamidoadenosine. This rank order indicates that inhibitions of both cyclic AMP and InsP3 production are mediated by adenosine A1 receptors. Responses to R-PIA were blocked by BW-A1433U (1 ,tM) or by pretreatment of cells with pertussis toxin. A greater amount of toxin was required to eliminate the effect of R-PIA on inositol phosphate than on cyclic AMP accumulation. These data indicate that adenosine, in addition to inhibiting cyclic AMP accumulation, decreases IPx production in GH3 cells, possibly by directly inhibiting phosphoinositide hydrolysis.
INTRODUCTION
A number of receptor-mediated biological actions of adenosine have been recognized (reviewed by Williams, 1987) . Since the discovery of adenosine receptors in brain (Sattin & Rall, 1970) , it has been determined that adenosine inhibits neurotransmitter release by binding to presynaptic A1 receptors (Phillis & Wu, 1981; Gustaffson et al., 1983; Dunwiddie et al., 1986) . Adenosine also has been reported to inhibit peptide-hormone secretion and cyclic AMP accumulation in GH4C1 cells (Dorflinger & Schonbrunn, 1985) . GH4C1 and GH3 cells are clonal rat pituitary tumour lines which synthesize and release prolactin and growth hormone.
Adenosine in various tissues has been shown to inhibit and to stimulate adenylate cyclase via A1 and A2 receptors, respectively (Van Calker et al., 1979; Londos et al., 1980) . Receptor subtypes can also be distinguished by a difference in the potency order of various agonists (Londos et al., 1980; Wolff et al., 1981) . Adenosinemediated inhibition of cerebellar glutamate release through an A1 receptor is prevented by pretreating the tissue with pertussis toxin (PTX) (Dolphin & Prestwich, 1985) . This bacterial toxin ADP-ribosylates an inhibitory guanine nucleotide-binding (G) protein, Gi, and prevents coupling of receptors to adenylate cyclase (Murayama & Ui, 1983) . Despite the clear involvement of cyclic AMP in many responses, adenosine may produce some of its actions independently of the cyclic nucleotide (Stone, 1985) . For instance, in dorsal root ganglion cells adenosine inhibits Ca2" currents directly via a G protein (Scott & Dolphin, 1987) . Adenosine and its analogues can potentiate histamine-stimulated inositol phosphate accumulation in guinea-pig cortex (Hollingsworth et al., 1986; Hill & Kendall, 1987) and inhibit the phosphoinositide (PI) pathway in frog paravertebral ganglia (Rubio & Bencherif, 1987) , mouse cerebellum (Hill & Kendall, 1988) , rat striatum (Petcoff & Cooper, 1987) , rat aorta (Long & Stone, 1987) and rat adipocytes (Schimmel, 1986) . Inhibition of the PI pathway has been implicated as a regulatory mechanism of agents other than adenosine. In hippocampal neurons, acidic amino acids inhibit carbachol-and histamine-stimulated inositol phosphate formation (Baudry et al., 1986) . In pituitary, dopamine was reported to inhibit angiotensin IIstimulated inositol phosphate generation and hormonal secretion (Enjalbert et al., 1986 ), but in a later study no effect of dopamine on inositol phosphate generation could be demonstrated (Canonico et al., 1986 ).
The present study was undertaken to investigate the mechanisms by which adenosine inhibits prolactin release from GH3 cells. These cells maintain many responses of the normal mammotroph in culture and have the advantage of being a more homologous group of cells (Gourdji et al., 1982) . Prolactin release from GH3 cells is enhanced by VIP, which increases cyclic AMP (Gourdji et al., 1979) , and by TRH, which stimulates the PI pathway (Martin, 1983) . Adenosine inhibits prolactin secretion stimulated by either VIP or TRH (Dorflinger & Schonbrunn, 1985) , but the mechanism of inhibition of both these secretory processes was unknown. (Linden et al., 1982) . The cyclic AMP, extracted from cells with 0.1 MHCl, was acetylated and assayed by automated radioimmunoassay (Brooker et al., 1976) . Prolactin released into the tissue-culture medium was collected after a 30 min incubation at 37°C and assayed by radioimmunoassay. Pretreatment of cells with 50 ng of PTX/ ml for 6 h was sufficient to block completely the effect of adenosine on cyclic AMP accumulation.
Extraction and assay of inositol phosphates. GH3 cells were incubated in serum-free Ham's F-10 medium with 0.1 % bovine serum albumin and 1 ,#Ci of myo-[3H]-inositol/ml at 37°C for 48 h. Longer incubation did not significantly increase incorporation of label into phospholipids (results not shown). The incubation medium was removed and cells were rapidly washed twice with Krebs bicarbonate-buffered medium (Krebs & Henseleit, 1932) at 37°C, pH 7.4, containing 119 mMNaCl, 4 mM-KCI, 1 mM-KH2PO4, 2 mM-MgSO4, 2 mMCaCl2, 10 mM-NaHCO , 5 mm-NaHepes, 0.2% glucose and 0.1 % bovine serum albumin. Drugs were made up and applied in Krebs medium with 10 mM-LiCl. In some experiments 1 mM-EGTA was added to Ca2+-free Krebs medium and applied to cells. Reactions were terminated by adding 0.5 M-HC104 with 5 mM-EDTA and 1 mMdiethylenetriaminepenta-acetic acid to prevent the precipitation of Mg2+ salts of the inositol phosphates. Plates were kept on ice for 30 min, and then cell extracts were transferred to centrifuge tubes containing sufficient K2C03 (5 M) to raise the pH to 8-9. Protein and perchlorate precipitates were pelleted by centrifugation, and the supernatants were applied to Dowex AG 1X8 (formate form) anion-exchange columns and eluted as described by Berridge et al. (1983) . An Martin (1986) . Reactions were terminated by adding chloroform/methanol/HCl (10:10:1, by vol.). Separation into two phases was promoted by adding 0.25 ml of 10 mM-EDTA and 0.1 mM-sodium orthovanadate. The organic phase was washed twice with 0.1 M-KCl/methanol (1: 1, v/v) and dried under a stream of N2. Lipids were deacylated by incubation for 20 min at room temperature in I ml of chloroform, 0.2 ml of methanol and 0.2 ml of 1 19: 1, v/v) . the reaction was stopped by adding 1 ml of chloroform, 0.6 ml of methanol and 0.6 ml of water. After phase separation the aqueous phase was removed and diluted with 6 ml of 6 mM-Na2B407 and applied to Dowex AG 1X8 columns (formate form). Sequential washes eluted the glycerophospholipids as follows: 5 mMNa2B407/0.18 M-ammonium formate, glycerophosphoinositol; 0.5 M-ammonium formate/0.1 M-formic acid, glycerophosphoinositol phosphate; 1 M-ammonium respectively. The stimulatory effects of both of these hormones were decreased by more than 50 % in the presence of 10 /M-R-PIA (Table 1 ). The adenosine Al-receptor antagonist BW-A1433U at a concentration of 1 ,UM, which has no effect on cyclic AMP phosphodiesterase activity (Daluge & Leighton, 1986; Clemo et al., 1987) (Table  4) . ADA and BW-A1433U also elevated basal and VIPstimulated cyclic AMP accumulation, suggesting that endogenous adenosine is released by GH3 cells in quantities sufficient to activate partially A1 receptors (Fig. 1) . Basal cyclic AMP contents increased from 11.6 to 15.8 pmol/well in the presence of ADA (1 unit/ml) (P < 0.001), but the maximal effect of the enzyme required in excess of 3 units/ml. Both the efficacy and the potency of VIP were significantly enhanced by both ADA and BW-A1433U (Fig. 1 ).
Adenosine and IPX accumulation
In order to examine the effects of drugs on PI metabolism, it was desirable to achieve a constant specific radioactivity of the radioactive inositol incorporated into lipids. Then changes in inositol phospholipid contents could be directly monitored by measuring the radioactive content of phosphoinositides and inositol phosphates. In the course of this study, GH3 cells were labelled to equilibrium in all experiments. The addition of 10 /tM-adenosine or -R-PIA decreased the IPX accumulation after a 10 min incubation with 100 nM-TRH in the presence of 10 mM-LiCl by 60 65o (P < 0.0001; data pooled from six experiments consisting of four replicates with each drug). This inhibition was abolished by 1 ,UM-BW-A1433U (Table 3) . No significant effect of BW-A1433U or ADA alone on basal or TRH-stimulated IPX accumulation could be demonstrated, suggesting little or no role for endogenous adenosine in the regulation of IPx production. In some experiments R-PIA was found to decrease significantly basal IPX production (Table 5) . Li' impedes breakdown of inositol sugars to free inositol (Drummond et al., 1984 (Table 4) . IPX accumulation in response to TRH decreased slightly when cells were pretreated with 100 ng of PTX/ml for 24 h, an observation also reported by Martin et al. (1986) . This may be a trophic effect, as serum-stimulated proliferation is inhibited in the presence of PTX (Murayama & Ui, 1987 doses did not decrease the IPX or cyclic AMP responses to TRH and VIP respectively. The efficacy rather than the potency (ED50 10 nM) of TRH was decreased by R-PIA (Fig. 2a) . Adenosine analogues inhibited TRH-stimulated IPx generation in a concentration-dependent manner, with the potency order CPA > PIA > NECA (Fig. 2b) , identical with that observed for inhibition of VIP-stimulated cyclic AMP accumulation ( Table 2) There was a lag of over 2 min before significant inhibition of TRH-stimulated IP, production was observed in the presence of R-PIA (Fig. 3) . In measuring 73 (Dufy et al., 1986; Schlegel et al., 1984) , [Ca2+]1 was elevated by depolarizing the plasma membrane with 140 mM-KCl or by adding maitotoxin, which activates Ca2+ channels (Takahashi et al., 1983 ) and elevates
[Ca2+]i in pituitary cells (Anderson & Cronin, 1987) . The effects of these agents are shown in Table 5 . IPX production measured in the presence of KCI and maitotoxin was still significantly decreased by R-PIA (Table 5 ). In cells incubated in 1.5 mM-Ca2+ or preincubated for 10 min in Ca2+-free buffer containing 1 mM-EGTA, 10 ,uM-R-PIA inhibited TRH-stimulated IPX generation by 52 % (P <0.001) and 49 % (P<0.01), respectively. After addition of 140 mM-KCl, inhibition of the TRH response was decreased to 28 00, but was still significant (P < 0.005) ( Table 5 ). In an additional experiment (results not shown), KCI produced a significant (P < 0.05) increase in basal IPX, as has been previously reported (Biden et al., 1987) independently three times and measured in the presence of 10 mM-LiCl. R-PIA had no effect on basal IPX contents (A). Error bars smaller than the symbols are not shown; * indicates significant inhibition by R-PIA (P < 0.01).
Effect of R-PIA on TRH-stimulated polyphosphoinositide hydrolysis TRH caused a modest decrease in Ptdlns (Fig. 4a ) and a rapid and transient decrease in PtdIns4P (Fig. 4b) and Ptdlns(4,5)P2 (Fig. 4c) . In the presence of R-PIA (10 /M), the TRH-stimulated hydrolysis of these phospholipids was almost completely prevented (Figs. 4a, 4b and 4c ). In two experiments each consisting of six replicates, basal concentrations of each of the three phospholipids were 6-10 % higher in the presence of R-PIA. The effects of R-PIA on the hydrolysis of phospholipids were not prevented by the addition of 1 /LM-forskolin (results not shown).
DISCUSSION
In this study we have shown that adenosine, via A1 receptors, inhibits not only VIP-stimulated prolactin release and cyclic AMP accumulation but also TRHstimulated prolactin release and PI breakdown. In agreement with the data of Imai & Gershengorn (1987) and Martin (1986) , it was observed that TRH produced a rapid loss of PtdIns4P and Ptd.In ( by GH3 cells in culture. In contrast with the effect of endogenous adenosine on cyclic AMP metabolism, no effect on basal or TRH-stimulated IPR production could be detected in this study. This may be a consequence of the fact that adenosine and other agonists are more potent as inhibitors of cyclic AMP production than of IPR generation. Evidence of autocrine inhibition by adenosine also has been observed in GH4Cl cells (Dorflinger & Schonbrunn, 1985) , adipocytes (Fain & Wieser 1975; Schimmel et al., 1987) and hippocampal I nerve terminals (Allgaier et al., 1987 (Doctrow & Lowenstein, 1987; O'Shea et al., 1987) . However, Ptdlns, PtdIns4P and Ptdlns(4,5)P2 all increased in the presence of 10 ,iM-R-PIA, suggesting that presence of 3 units of adenosine receptors are regulating an enzyme such as ) were assayed in the phospholipase C, which hydrolyses all three phosphotages of initial values inositides (Wilson et al., 1984 . In I addition, PTX abolished the effect of R-PIA on cyclic AMP accumulation at a dose which did not completely abolish its effect on PI metabolism. Furthermore, agents known to inhibit cyclic AMP accumulation in GH3 cells (e.g. somatostatin and carbachol) have no effect on TRH-stimulated IP accumulation or phospholipid labelling (Yajima et al., 1986; Sutton & Martin, 1982) . The transduction mechanisms of several receptors mediating PI breakdown appear to involve guaninenucleotide-regulatory (G) proteins (for review see AbdelLatif, 1986) . The name Gp (p for phospholipid) has been coined to describe this protein (Berridge, 1987) , although it appears that there may be more than one Gp with different sensitivities to PTX. In GH3 cells, InsP3 release can be stimulated by GTP analogues, but TRHstimulated inositol phosphate accumulation is not sensitive to PTX Wojcikiewicz et al., 1986) . The inhibition of IP, metabolism by adenosine was only partially obviated by preincubating the cells with PTX at the same concentration (50 ng/ml for 24 h), which completely blocked inhibition of adenylate cyclase. This result suggests either that there are two G proteins coupled to adenosine receptors, only one of which is sensitive to PTX at this concentration, or that the effect of adenosine on PI metabolism requires less functional G protein than is required to inhibit cyclic AMP production. In adipocytes, adenosine can inhibit both isoprenalineand phenylephrine-stimulated respiration, but these effects also differ in their sensitivity to PTX treatment (Schimmel et al., 1987) . The inhibition of the PI-linked phenylephrine response by adenosine was blocked by PTX treatment only when all G1 present was ADPribosylated by the toxin, whereas incomplete ADPribosylation of G, by PTX was sufficient to block adenosine inhibition of the adenylate cyclase-linked isoprenaline effect. A third example of differential sensitivity to PTX was described by Ashkenazi et al. (1987) (Wojcikiewicz et al., 1986; Martin et al., 1986; Yajima et al., 1986 ). This PTX substrate has been further resolved into two bands, corresponding closely to G, and G. (Zysk et al., 1986) .
Single receptors coupled to multiple effector systems have been noted in several tissues. For instance, in the cardiac atrium, both adenosine and acetylcholine inhibit adenylate cyclase and activate K+ channels, possibly via the same receptors coupled to different G proteins (Yatani et al., 1987 In a pituitary cell line, Lewis et al. (1986) found that somatostatin receptors are coupled to inhibition of adenylate cyclase and are coupled to Ca2" channels by PTX-sensitive guanine nucleotide binding proteins. Studies in vitro of PI-hydrolysing phosphodiesterases from numerous sources have indicated that maximal activation of this enzyme requires concentrations of Ca2" well above intracellular values (Irvine, 1982) . TRH stimulation of GH3 cells or addition of guanine nucleotide to permeabilized neutrophils (Bradford & Rubin, 1986; Smith et al., 1986) 
